Nonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residues, methods for their preparation, pharmaceutical compounds containing them, and their pharmaceutical use
申请人:SYNTEX (U.S.A.) INC.
公开号:EP0042753A1
公开(公告)日:1981-12-30
Nonapeptide and decapeptide analogs of LH-RH of the formula
(pyro)Glu-His-V-Ser-W-X-Y-Arg-Pro-Z (I) and the pharmaceutically acceptable salts thereof wherein:
V is tryptophyl, phenylalanyl or 3-(1-naphthyl)-L-alanyl;
W is tyrosyl, phenylalanyl or 3-(1-pentafluorophenyl)-L-alanyl;
X is a D-amino acid residue of the formula:
wherein R is a heterocyclic aryl containing radical selected from radicals represented by the following structural formulas:
wherein A and A' are independently selected from hydrogen, lower alkyl, chlorine, and bromine, and G is selected from oxygen, nitrogen, and sulfur;
Y is leucyl, isoleucyl, nor-leucyl or N-methyl-leucyl;
Z is glycinamide or -NH-R', wherein:
R' is lower alkyl, cycloalkyl, fluoro lower alkyl or O II -NH-C-NH-R2 wherein
R2 is hydrogen or lower alkyl,
are disclosed. These compounds exhibit potent LH-RH agonist properties.
式中的 LH-RH 的非肽和十肽类似物
(pyro)Glu-His-V-Ser-W-X-Y-Arg-Pro-Z (I)及其药学上可接受的盐类 其中:
V 是色氨酰、苯丙氨酰或 3-(1-萘基)-L-丙氨酰;
W 是酪氨酰、苯丙氨酰或 3-(1-五氟苯基)-L-丙氨酰;
X 是式中的 D-氨基酸残基:
其中 R 是杂环芳基,选自下列结构式所代表的基团:
其中 A 和 A'独立地选自氢、低级烷基、氯和溴,G 选自氧、氮和硫;
Y 是亮氨酰,异亮氨酰,非亮氨酰或 N-甲基亮氨酰;
Z 是甘氨酰胺或-NH-R',其中:
R' 是低级烷基、环烷基、氟低级烷基或 O II -NH-C-NH-R2 其中
R2 是氢或低级烷基、
公开了这些化合物。这些化合物具有强效的 LH-RH 激动剂特性。
US4318905A
申请人:——
公开号:US4318905A
公开(公告)日:1982-03-09
[EN] BENZIMIDAZOLE OR INDOLE AMIDES AS INHIBITORS OF PIN1<br/>[FR] AMIDES DE BENZIMIDAZOLE OU D'INDOLE EN TANT QU'INHIBITEURS DE PIN1
申请人:PFIZER
公开号:WO2006040646A1
公开(公告)日:2006-04-20
The invention relates to compounds of the formula (1) and to pharmaceutically acceptable salts and solvates thereof, wherein the variables are defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula (1) and to pharmaceutical compositions for treating such disorders that contain the compounds of formula (1). The invention also relates to methods of preparing the compounds of formula (1).